Protective Order Forecloses Participation of Litigation Counsel in Motion to Amend Process Before the PTAB

May 17, 2024

Reading Time : 3 min

In keeping with precedent, a judge in the District of Delaware issued an oral order restricting the extent of permissible activities for litigation counsel before the Patent Trial and Appeal Board. The order resolved a protective order dispute over the proper scope of a patent prosecution bar, concluding that litigation counsel that had access to confidential information is restricted from participating in the motion to amend process in an IPR.

Plaintiffs brought an action in the District of Delaware alleging that defendants infringed several patents. Defendants responded by filing IPR petitions at the PTAB challenging the patentability of each asserted patent. Before discovery commenced in the district court litigation, the parties met-and-conferred on a protective order. During those negotiations, a dispute arose over the scope of a proposed prosecution bar. While both parties agreed that litigation counsel that had access to defendants’ confidential information could participate generally in the IPRs, they disagreed over counsels’ involvement in the IPR motion to amend process. Plaintiffs’ proposed protective order language made clear that arguing the patentability of claims presented in a motion to amend should not be barred. Defendants’ proposed language, on the other hand, prevented litigation counsel from participating in any way in a motion to amend, including drafting a motion to amend and arguing the patentability of the amended claims.

In advocating for their proposed protective order language, plaintiffs pointed out that claims in an IPR can only be narrowed. Therefore, arguing the patentability of amended claims presents no more risk of inadvertent disclosure of confidential information than arguing the patentability of original claims, which defendants’ proposal would permit. Plaintiffs further contended that defendants’ proposed language banning litigation counsel from participating in motions to amend would severely prejudice plaintiffs by depriving them of their choice of counsel, resulting in duplication of efforts and increased costs.

Defendants disagreed and argued that allowing litigation counsel with access to defendants’ confidential information to participate in the motion to amend process would subject even the most scrupulous counsel to the risk of influencing the scope of proposed amended claims with that confidential information in mind. That risk, defendants claimed, is further exacerbated by the fact that (during the motion to amend process) the patent owner can change the scope of the claims after receiving preliminary guidance from the board. According to defendants, in arguing a motion to amend, the patent owner may advance arguments that affect the claims’ scope, including via claim construction or disclaimer. Because patent owners can potentially obtain new claims with different scope, in defendants’ view, a bright-line rule prohibiting litigation counsel that received confidential information from participating in motions to amend is necessary. Finally, defendants argued that plaintiffs would suffer no prejudice by the ban because they could select counsel from the same law firm as litigation counsel to argue motions to amend.

Ultimately, the court adopted defendants’ language and in doing so noted that it is consistent with the “balanced approach” taken previously in the District of Delaware that allowed litigation counsel to participate in IPRs except as to activities related to amending claims. The court further explained that although claims can only be narrowed in an IPR, there is still a risk that the patent owner could use confidential information to craft claims that avoid prior art but still cover defendants’ product. Moreover, the court emphasized that plaintiffs failed to explain how their litigation counsel could draft or argue a motion to amend without discussing the claim amendments with the patent prosecutors. The court concluded that allowing even limited involvement in the motion to amend process “could defeat the purpose of implementing the prosecution bar in the first place.”

Practice Tip: In negotiating the terms of a protective order, parties should be intimately familiar with precedent in the jurisdiction in question. If appropriate, defendants should consider seeking to include language that unambiguously restricts plaintiff’s litigation counsel that had access to defendant’s confidential information from working on motions to amend in any co-pending IPR. Plaintiffs, on the other hand, should consider shielding at least one attorney on their team from defendant’s confidential information to ensure that the attorney can participate in a motion to amend in the IPR, including by drafting and arguing the motion to amend.

Aerin Med. Inc., et al. v. Neurent Med. Inc., et al., Case No. 1-23-cv-00756, D.I. 66 (D. Del. May 8, 2024) (Fallon, J.).

Share This Insight

Previous Entries

IP Newsflash

March 24, 2025

The Federal Circuit affirmed a Patent Trial and Appeal Board (PTAB) final written decision holding that the prior art exception of AIA Section 102(b)(2)(B) does not apply to a prior sale by an inventor when the sale is conducted in private. According to the Federal Circuit, a sale must disclose the relevant aspects of the invention to the public to qualify for the prior art exception of Section 102(b)(2)(B).

...

Read More

IP Newsflash

March 21, 2025

Under the Lanham Act, a plaintiff who prevails on a trademark infringement claim may be entitled to recover the “defendant’s profits” as damages. The Supreme Court in Dewberry Group, Inc. v. Dewberry Engineers Inc. unanimously construed “defendant’s profits” in 35 USC § 1117(a) to mean that only the named defendant’s profits can be awarded, not the profits of other related corporate entities. The Court, however, left open the possibility that other language in § 1117(a) may allow for damages linked to the profits of related entities, if properly raised and supported.

...

Read More

IP Newsflash

March 13, 2025

In a series of rulings on a motion in limine, the District of Delaware recently distinguished between what qualifies as being incorporated by reference and what does not for the purposes of an anticipation defense. In short, a parenthetical citation was held to be insufficient, while three passages discussing a cited reference met the test.

...

Read More

IP Newsflash

March 4, 2025

On February 28, 2025, the USPTO announced that it was rescinding former Director Vidal’s 2022 memorandum on discretionary denials by the Patent Trial and Appeal Board. The 2022 memorandum effectively narrowed the application of discretionary denials in cases with parallel district court litigation by specifying instances where discretionary denial could not be issued. With the withdrawal of the memorandum, individual PTAB panels will regain flexibility in weighing discretionary denials. While the long-term effect of that increased flexibility is not yet known, the immediate effect is likely to be a shift towards the discretionary analysis applied by PTAB panels before the issuance of the memorandum.

...

Read More

IP Newsflash

March 3, 2025

A District of Delaware judge recently granted a defendant’s motion to include a patent prosecution bar in its proposed protective order after determining that litigation counsel’s ability to practice before the Patent Office—without ever having represented the plaintiffs at the Patent Office in the past—weighed heavily in favor of the bar.

...

Read More

IP Newsflash

February 12, 2025

The Federal Circuit recently reversed a district court decision that found a patent that did not describe after-arising technology failed to satisfy the written description requirement. In so doing, the Federal Circuit explained that written description and enablement are evaluated based on the subject matter that is claimed, not the products that practice those claims. As a result, the patentee was not required to describe unclaimed, later-discovered features of the accused products despite the broad language in the claims that undisputedly covered the products.

...

Read More

IP Newsflash

January 24, 2025

The District of Delaware recently rejected a patentee’s argument that non-production of an opinion letter from counsel, combined with knowledge of the patent, warranted a finding that defendant induced infringement.

...

Read More

IP Newsflash

January 17, 2025

The District of Delaware recently denied a motion to dismiss a patent infringement complaint involving gene editing technology that sought relief under the Safe Harbor Provision of the Hatch-Waxman Act. Specifically, the court found the patentee’s complaint sufficiently alleged at least some uses of the claimed technology that, when taken as true, were not solely uses of a “patented invention” that were “reasonably related” to an FDA submission.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.